Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608 June 11, 2024
Adaptimmune and Galapagos Collaborate on uza-cel in Head & Neck Cancer and Potential Future Solid Tumor Indications June 4, 2024
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt June 4, 2024
Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology June 3, 2024
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs June 3, 2024
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS(TM) First in Human Study June 3, 2024
Dragonfly Announces Clinical Collaboration to Evaluate DF9001 in Combination with KEYTRUDA® in Patients with Solid Tumors May 29, 2024
Nanobiotix and Janssen aligned at the collaboration’s Joint Strategy Committee to transfer the global sponsorship of the Ph 3 pivotal head and neck cancer trial May 29, 2024
ReEngage Therapeutics Launches to Develop ACSS2 Inhibitor Compounds for Cancer Indications May 29, 2024
Indapta Therapeutics Awarded $4.5 Million by CPRIT to Advance Clinical Development of its Allogenic Natural Killer Cell Therapy May 29, 2024
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines May 29, 2024
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases May 29, 2024
Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies May 29, 2024
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on Ph 2 Trial of Zotatifin Combo in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer May 21, 2024
Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics May 21, 2024
AstraZeneca plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore May 21, 2024
FogPharma and ARTBIO Announce Collaboration to Co-Develop Multiple Helicon™-Enabled Alpha-Particle Radioligand Therapies for the Treatment of Cancer May 21, 2024
Aulos Bioscience Enters Into Clinical Trial Collaboration and Supply Agreement With Merck To Study Combination of Bavencio® With AU-007 May 21, 2024
Phanes Therapeutics Announces Clinical Supply Agreement with Roche to Evaluate PT217 in Combination with an anti-PD-L1 Therapy May 15, 2024
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA May 15, 2024
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of XCE853 May 14, 2024
Kite and Arcellx share design of global Ph 3 trial, iMMagine-3, to evaluate anito-cel in patients exposed to both an lMiD drug and an anti-CD38 mAb May 14, 2024
